实时超声影像融合联合胆管腔内超声造影在PTCD中的应用
本研究为回顾性队列研究,纳入71例接受PTCD的患者,比较RVS联合IB-CEUS引导与DSA引导的效果。结果显示RVS+IB-CEUS组术中穿刺次数和术后并发症发生率均显著低于DSA组,复杂胆管患者穿刺次数也较少,但并发症差异不显著。
要点
- RVS联合IB-CEUS引导PTCD可减少术中穿刺次数。
- 该技术可降低术后并发症发生率,尤其简单胆管条件者。
- 复杂胆管条件患者仍可从PTCD中获益。
核心结论
- RVS联合IB-CEUS引导下行PTCD有助于减少术中穿刺次数及术后并发症。
- 复杂胆管条件患者仍可从PTCD中获益。
研究设计与样本
- 回顾性队列研究,纳入2021年5月至2022年8月南昌大学第二附属医院肝胆胰外科71例PTCD患者。
- 男性36例,女性35例,年龄35~94岁。
- 按引导方式分为RVS联合IB-CEUS组(n=36)和DSA组(n=35)。
主要发现
- RVS+IB-CEUS组与DSA组穿刺次数分别为(1.0±0.2)次和(2.2±1.4)次,t=-5.148,P<0.01。
- RVS+IB-CEUS组与DSA组术后并发症发生率分别为2.8%(1/35)和17.1%(6/36),P=0.049。
- 简单胆管亚组中,RVS+IB-CEUS组和DSA组穿刺次数分别为(1.0±0.2)次和(2.2±1.6)次,t=-3.606,P<0.01。
- 复杂胆管亚组中,RVS+IB-CEUS组和DSA组穿刺次数分别为(1.0±0.0)次和(2.4±0.4)次,t=-3.959,P=0.002。
- 简单胆管亚组中,RVS+IB-CEUS组并发症发生率为0(0/24),DSA组为19.2%(5/26),P=0.031;复杂胆管亚组差异无统计学意义(1/12比1/9,P=0.686)。
临床怎么用
- 在PTCD术中可考虑采用RVS联合IB-CEUS引导以降低穿刺次数和并发症。
- 对于复杂胆管条件患者,该引导方式仍可帮助完成PTCD。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the application value of real-time virtual sonography (RVS) combined with intraductal biliary contrast-enhanced ultrasound (IB-CEUS) in percutaneous transhepatic cholangial drainage (PTCD). Methods: This retrospective cohort study included data from 71 patients who underwent PTCD at the Department of Hepatobiliary and Pancreatic Surgery in the Second Affiliated Hospital of Nanchang University between May 2021 and August 2022. There were 36 male and 35 female patients,aged 35 to 94 years. Based on the guidance modality used,patients were divided into two groups: the RVS combined with IB-CEUS group (n=36) and the digital subtraction angiography (DSA) group (n=35). PTCD was performed under the guidance of RVS combined with IB-CEUS in the RVS+IB-CEUS group,and under conventional DSA fluoroscopic guidance in the DSA group. Two clinicians classified the biliary conditions as either simple or complex based on preoperative ultrasound and CT (or MRI) imaging. Statistical analyses were conducted using independent sample t-tests,rank-sum tests,χ² tests,or Fisher's exact tests,as appropriate. Results: Significant differences were observed between the RVS+IB-CEUS group and the DSA group in terms of the number of punctures (1.0±0.2 vs. 2.2±1.4,t=-5.148,P<0.01) and postoperative complication rate(2.8% (1/35) vs. 17.1% (6/36),P=0.049). There were 9 patients with complex biliary conditions in the DSA group and 12 in the RVS+IB-CEUS group. The number of punctures in both the simple and complex subgroups of the RVS+IB-CEUS group(1.0±0.2 and 1.0±0.0) remained lower than that in the corresponding DSA subgroups(2.2±1.6 and 2.4±0.4) (t=-3.606,P<0.01;t=-3.959,P=0.002). Moreover,the complication rate in the simple biliary subgroup of the RVS+IB-CEUS group was significantly lower than that of the DSA group(0 (0/24) vs. 19.2% (5/26), P=0.031),whereas no significant difference was found in the complex biliary subgroup (1/12 vs. 1/9,P=0.686). Conclusion: Guided by RVS and IB-CEUS, PTCD can help reduce the number of punctures during surgery and postoperative complications, and patients with complex bile duct conditions can still benefit from PTCD. 目的: 探讨实时超声影像融合(RVS)联合经胆管腔内超声造影(IB-CEUS)在经皮肝胆管穿刺置管引流术(PTCD)中的应用价值。 方法: 本研究为回顾性队列研究。回顾性收集2021年5月至2022年8月南昌大学第二附属医院肝胆胰外科收治的接受PTCD治疗的71例患者资料。男性36例,女性35例,年龄35~94岁。按照引导方式不同将患者分为RVS联合IB-CEUS组(n=36)和数字减影血管造影(DSA)组(n=35)。RVS联合IB-CEUS组在RVS联合IB-CEUS引导下行PTCD,DSA组在常规DSA透视引导下行PTCD。由两名临床医师根据术前超声和CT(或MRI)检查图像将胆管条件分为复杂和简单两种情况。分别采用独立样本t检验、秩和检验、χ2检验或Fisher确切概率法对组间数据进行统计学分析。 结果: RVS联合IB-CEUS组和DSA组患者术中穿刺次数[(1.0±0.2)次比(2.2±1.4)次;t=-5.148,P<0.01]及术后并发症发生率[2.8%(1/35)比17.1(6/36);P=0.049]的差异均有统计学意义。DSA组和RVS联合IB-CEUS组分别有9例和12例为复杂胆管。RVS联合IB-CEUS组中简单胆管亚组和复杂胆管亚组的穿刺次数[(1.0±0.2)次和(1.0±0.0)次]仍低于DSA 组[(2.2±1.6)次和(2.4±0.4)次](t=-3.606,P<0.01;t=-3.959,P=0.002)。RVS联合IB-CEUS组中简单胆管亚组的并发症发生率[0(0/24)]亦低于DSA组[19.2%(5/26)](P=0.031),但复杂胆管亚组的差异无统计学意义(1/12比1/9)(P=0.686)。 结论: 在RVS联合IB-CEUS引导下行PTCD有助于减少术中穿刺次数及术后并发症,且复杂胆管条件患者仍可从PTCD中获益。.
引用
- Wu HH, Yi JW, Hu ZG, et al. [Application of real-time virtual sonography combined with intraductal biliary contrast-enhanced ultrasound in percutaneous transhepatic cholangial drainage]. Zhonghua Wai Ke Za Zhi. 2025. PMID: 40556402. doi:10.3760/cma.j.cn112139-20241228-00596
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。